28. Trypsin Trypsinogen Activate other proenzymes Phospholipase Proelastase Disintegration of fat cells Damage elastic fibers of b.v. Acute Pancreatitis Prekallikrein Kallikrein Kinin system Hageman factor Clotting system Complement system Inflammation Small vessel thromboses
78. A cross-section through the head of the pancreas and adjacent CBD showing both an ill-defined mass in the pancreatic substance and the green discoloration of the duct resulting from total obstruction to bile flow.
79.
80.
81.
82. Poorly formed glands are present in densely fibrotic stroma within the pancreatic substance with presence of some inflammatory cells.
83.
84.
85.
86.
87.
88.
89.
90. American Joint Committee for Cancer Staging for Carcinoma of the Pancreas TNM classification criteria T1 No direct extension of the primary beyond the pancreas T2 Limited direct extension to the duodenum, bile duct, or stomach T3 Advanced direct extension incompatible with surgical resection TX Direct extension not assessed N0 Regional nodes not involved N1 Regional nodes involved NX Regional LN not assessed
91. American Joint Committee for Cancer Staging for Carcinoma of the Pancreas TNM classification criteria M0 No distant metastasis M1 Distant metastasis present MX Distant metastasis not assessed TNM Stages Stage I T1-2, N0, M0 Stage II T3, N0, M0 Stage III T1-T3, N1, M0 Stage IV Any T or N, M1
103. What is glucose? Glucose is an essential nutrient that provides energy for the proper functioning of the body cells. MAN needs glucose to work CAR needs fuel to move FUEL
104. Blood Glycogenolysis (-) GLUCAGON (+) INSULIN Fed State Pyruvate/Lactate Amino acids Glycerol / FFA Glycogenesis X X *All cells
105. Blood Glycogenolysis (+) GLUCAGON (-) INSULIN Postabsorptive / Fasting State Pyruvate/Lactate Amino acids Glycerol / FFA Glycogenesis *6-8hrs after a meal First 24-48hrs Preferentially used by brain, & other non-insulin dependent tissues X
106. Blood Glycogenolysis (+) GLUCAGON EPINEPHRINE CORTISOL GROWTH HORMONE (-) INSULIN Postabsorptive / Fasting State Glycogenesis After 48hrs of fast Lipolysis Proteolysis Ketogenesis Ketones for brain Pyruvate/Lactate Amino acids Glycerol / FFA
107.
108.
109.
110.
111.
112. Classification of Glucose Transport According to Their Tissue Distribution and Functional Regulation Glucose Organ Transporter HK Coupler Classification Brain GLUT 1 HK-I Insulin independent Erythrocyte GLUT 1 HK-I Insulin independent Adipocyte GLUT 4 HK-II Insulin dependent Muscle GLUT 4 HK-II Insulin dependent Liver GLUT 2 HK-IVL Glucose sensor GK -cell GLUT 2 HK-IVB Glucose sensor (Glucokinase) Gut GLUT 3-symporter - Sodium dependent Kidney GLUT 3-symporter - Sodium dependent
121. Cell = Powerplant Keyhole = Insulin Receptor G G G G G G G Key = Insulin Glucose
122. Keyhole = Insulin Receptor G G G G G Key = Insulin CELL = POWERPLANT
123. G G G G G CELL = POWERPLANT Energy G G G G G G
124. DIABETES Greek MELLITUS Latin Sweet as honey To pass water like a siphon
125. G G G G G Type 1 DM insulin (key) absent G G G G G Type 2 DM defective insulin receptor (keyhole) with insufficient insulin Insufficient production of insulin or the inability of cells to use insulin (insulin resistance). What causes it?
126. “ Sweet Urine” Diabetes Mellitus group of metabolic disorders characterized by high blood sugar levels Hyperglycemia can lead to spillage of glucose into the urine (> 180 renal threshold)
129. SYMPTOMS OF DIABETES Poor Wound Healing Weight Loss Weakness and Fatigue Blurring of Vision
130. SYMPTOMS OF DIABETES Many have no symptoms. They are noted to have high blood sugar on testing.
131. RISK FACTORS FOR DIABETES Heredity Old Age Obesity Mothers of large babies
132. Criteria for diagnosis of DM ADA 2004 Note: criteria should be confirmed by repeat testing on a different day.
133. CRITERIA FOR DIAGNOSIS OF DIABETES MELLITUS “ prediabetics” – risk for developing type 2 DM (40% risk over 5yrs) & CV disease Level of glycemia at which diabetic chronic complications occur American Diabetes Association 8 hr Fasting Blood Sugar 2 hours after 75g glucose (OGTT) NORMAL < 100 mg/dL < 140 mg/dL IMPAIRED FASTING GLYCEMIA (IFG) 100 and < 126 mg/dL --- IMPAIRED GLUCOSE TOLERANCE (IGT) --- 140 and < 200 mg/dL DIABETES MELLITUS 126 mg/dL 200 mg/dL Symptoms of diabetes and Random Blood Sugar of 200 mg/dL
134.
135. Etiologic Classification of DM exocrine I. II. III. IV. Based on pathologic process that leads to hyperglycemia
136.
137.
138. Etiologic Classification of DM I. II. III. IV. Genetic predisposition Immunologic trigger No DM with DM Beta cell mass (%) 100 50 20 0 Time (years) Overt DM
139.
140.
141.
142. Three Pathophysiologic Mechanisms of Type 2 Diabetes Glucose (G) Insulin (I) I I I I I I I G G G G G G G G I G G G I G Fasting hyperglycemia Postprandial hyperglycemia Carbohydrate Impaired insulin secretion Excessive fatty acid release Reduced peripheral glucose Uptake and usage Excess liver glucose output (gluconeogenesis) Resistance to the action of insulin
143.
144. Natural history of type 2 diabetes: a progressive disease Post-prandial glucose Abnormal glucose tolerance Insulin resistance Increased insulin resistance Fasting glucose Hyperglycemia Insulin secretion Hyperinsulinemia, then -cell failure Adapted from International Diabetes Center (IDC), Minneapolis, Minnesota. Normal IGT Type 2 diabetes
145.
146.
147.
148.
149.
150.
151.
152.
153.
154.
155.
156. Glycemic goals 1 American Diabetes Association. Diabetes Care 2004; 27:S15–S35. 2 American Diabetes Association. Diabetes Care 2002; 25:S35–S49. 3 American Association of Clinical Endocrinologists. Endocrine Pract 2002; 8 (Suppl. 1):40–82. 4 European Diabetes Policy Group. Diabet Med 1999; 16:716–730. Fasting/pre-prandial plasma glucose < 140 < 180 Postprandial plasma glucose < 110 90–130 Biochemical index AACE 3 ADA 1,2 mg/dl mmol/l mg/dl mmol/l 5.0–7.2 < 10.0 < 6.5 < 7 HbA 1c (%) < 6.0 < 7.8
157.
158.
159. It cannot be cured. But it can be controlled by keeping blood sugar level within normal range. Diabetes Mellitus
183. What is a good self-testing blood glucose goal? Your doctor will set the appropriate goal for you. The self-testing blood glucose goals for most people with diabetes are as follows: Premeals 80-120mg/dL At bedtime 100-140mg/dL
206. Caring for Your TEETH A film of bacteria, saliva and food particles (dental plaque) constantly forms on the teeth. Bacteria feed on sugars and starches in foods and produce acids that damage teeth enamel.
207. Caring for Your TEETH High blood sugar gives bacteria more food supply producing more acid, damaging the enamel leading to tooth decay.
208. Caring for Your TEETH If plaques are not removed with brushing and flossing, it hardens under the gumline into “tartar”. Tartar irritates the gums causing gum inflammation (gingivitis).
209. Brush your teeth at least twice a day especially after each meal and snack. Use soft-bristled brush. Floss daily . Caring for Your TEETH
210. See your dentist at least 2x a year. Consult your diabetes doctor prior to any dental extraction. Caring for Your TEETH
234. INSULIN If your pancreas no longer makes enough insulin, you need to take insulin. You inject the insulin just under the skin with a small, short needle.
245. B LOOD G L U C O S E mg/dL Hypoglycemia: Symptoms & Signs LETHARGY COMA CONVULSIONS Sweating Tremor Palpitations Irritablity PERMANENT DAMAGE DEATH HEADACHE 90 - 80 - 70 - 60 - 50 - 40 - 30 - 20 - 10 -
The consequences of insulin resistance at the tissue level include reduced insulin-dependent glucose uptake into liver, adipose tissue and muscle. Combined with excessive glucose production by the liver, this leads to hyperglycemia, which in turn causes a compensatory increase in insulin secretion. The -cells of the pancreas are unable to sustain this increase in insulin secretion, thus the -cells fail, and insulin secretion becomes defective ( -cell dysfunction). In addition, excessive breakdown of triglycerides in the adipose tissue leads to increased circulating free fatty acids. This is particularly important since, not only do free fatty acids compete for glucose during metabolism, but there is also increasing evidence that elevated free fatty acids are toxic to the pancreas, in addition to promoting further hepatic glucose output. DeFronzo RA, et al . Diabetes Care 1992; 15: 318–354.
Insulin resistance is a reduced biological response to circulating insulin in target tissues 1 Insulin resistance causes an increase in the level of endogenous insulin required to achieve glycemic control, forcing the pancreas to release more insulin 2 When the -cells are unable to produce sufficient insulin to compensate for insulin resistance, fasting plasma glucose rises, leading to the onset of type 2 diabetes 2 1. Groop LC. Etiology of non-insulin-dependent diabetes mellitus. In Molecular Pathogenesis of Diabetes Mellitus , vol. 22, 1997; pp. 131–156. Edited by RDG Leslie. Basel: Karger. 2. Edelman SV. Type II diabetes mellitus. Adv Intern Med 1998; 43: 449–500.
Circulating serum glucose binds irreversibly to the N-terminal valine within the beta chain of the haemoglobin (Hb) molecule, creating A1C 1 It is currently accepted that A1C yields the best overall measurement of blood glucose control 2 A1C levels provide an objective index of glycaemic control for the past 2 to 3 months, based on the turnover of Hb in red blood cells 3 Importantly, increases in A1C levels reflect both the rise in fasting/preprandial blood glucose levels and postprandial glucose levels; thus, normalisation of A1C levels may require control of both pre- and postprandial glucose levels 3 1. Pickup JC. Diabetic control and its measurement. In: Pickup JC, Williams G, eds. Textbook of Diabetes . 3rd ed. Boston, Mass: Blackwell Science; 2003. 2. Clark N. Goals of treatment. In: Leahy JL, Cefalu WT, eds. Insulin Therapy . New York, NY: Marcel Dekker, Inc.; 2002:13-20. 3. Cefalu WT. Rationale for and strategies to achieve glycemic control. In: Leahy JL, Cefalu WT, eds. Insulin Therapy . New York, NY: Marcel Dekker, Inc.; 2002:1-11.